Morepen Labs lands record Rs. 825 crore global CDMO contract
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
Landmark studies have shown that rapid TXA administration can significantly reduce mortality
Investment to expand manufacturing and global medicine supply capacity
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
Vivo Bio Tech will have end-to-end responsibility for conducting the full spectrum of pre-clinical safety and regulatory studies
Commercial production is expected to begin soon
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
Subscribe To Our Newsletter & Stay Updated